Integr-algal

该项目通过将光养藻类生产与下游加工（从藻类中提取欧米茄3）相结合，解决了加强光养藻类生产高价值天然产品的挑战。目的是生产高价值的Omega-3多不饱和脂肪酸（PUFAs），用作活性药物成分（api）或食品补充剂。如果成功，这种新工艺将导致藻类的持续生长、产品的形成和回收。新工艺将为从鱼类中提取PUFAs提供一种商业上可行的替代方法，从而有助于为素食消费者提供可持续的来源。在饮食中加入omega -3脂肪酸（EPA和二十二碳六烯酸- DHA）与英国政府的福祉战略和维持日益老龄化的英国人口的健康有关。发展中国家的人口老龄化和含油鱼类供应的减少将意味着未来25年欧米伽3 （EPA）替代来源的市场将不断增长。

This project addresses the challenge of intensifying phototrophic algal production of high value natural products by integrating the it with downstream processing (extraction of Omega 3s from Algae). The aim is to produce high value Omega-3 polyunsaturated fatty acids (PUFAs), for use as active pharmaceutical ingredients (APIs) or food supplements. The novel process will, if successful, result in continuous growth of the algae, product formation and recovery. The new process will provide a commercially viable alternative to the extraction of PUFAs from fish, thus helping to provide a sustainable source for vegetarian consumers. The incorporation of Omega-3s (EPA and docosahexaenoic acid – DHA) into diet is relevant to the UK Government’s strategy for well-being and maintaining the health of an increasingly aging UK population. The aging population in developing countries and dwindling oily fish supplies will mean a growing market for alternative sources of Omega 3 (EPA) in the next 25 years.